Oct 14 UnitedHealth Group Inc on Wednesday took a conservative stance toward its expectations for 2021, citing uncertainties related to the COVID-19 pandemic, but raised its profit forecast for this year after third-quarter earnings beat estimates.
As evidence grew this spring that the drug remdesivir was helping COVID-19 patients, some Wall Street investors bet on analysts’ estimates that its maker, Gilead Sciences Inc, could charge up to $10,000 for the treatment.
Alphabet Inc's life sciences division Verily is partnering with reinsurer Swiss Re to launch a unit to provide stop-loss insurance, a financial product purchased by employers to cover unexpected and large employee healthcare costs.
The U.S. Food and Drug Administration rejected BioMarin Pharmaceutical Inc's gene therapy for bleeding disorder hemophilia A citing the need for longer-term data, the drugmaker said on Wednesday, potentially pushing any approval out to 2022.
NEW YORK Late in March, Laura Gross, 72, was recovering from gall bladder surgery in her Fort Lee, New Jersey, home when she became sick again.
NEW YORK, Aug 3 Late in March, Laura Gross, 72, was recovering from gall bladder surgery in her Fort Lee, New Jersey, home when she became sick again.
Health insurer Cigna Corp beat Wall Street expectations for second-quarter profit on Thursday, helped by lower medical costs from delayed surgical procedures and strong sales from its pharmacy benefits business.
Anthem Inc reported a quarterly profit that topped Wall Street expectations on Wednesday, aided by lower medical costs as people delayed non-essential procedures during the first surge of the U.S. coronavirus outbreak.
July 29 Anthem Inc reported a quarterly profit that topped Wall Street expectations on Wednesday, aided by lower medical costs as people delayed non-essential procedures during the first surge of the U.S. coronavirus outbreak.
NEW YORK More than half of U.S. companies surveyed by benefits company Mercer are starting COVID-19 contact tracing programs in their workplace with employees venturing back to offices even as new cases soar nationally.
Armenia's prime minister said on Wednesday he saw no possibility of a diplomatic solution at this stage in the conflict with Azerbaijan over the mountain enclave of Nagorno-Karabakh.